Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: - | CAS number: -
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Genetic toxicity: in vitro
Administrative data
- Endpoint:
- in vitro gene mutation study in bacteria
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- From January 26th, 2017 to January 30th, 2017
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- study well documented, meets generally accepted scientific principles, acceptable for assessment
- Remarks:
- Study carried out with a 57.7 % water solution of the test item. In addition, only three strains were used
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 2 017
Materials and methods
Test guideline
- Qualifier:
- equivalent or similar to guideline
- Guideline:
- OECD Guideline 471 (Bacterial Reverse Mutation Assay)
- GLP compliance:
- yes
- Type of assay:
- bacterial reverse mutation assay
Test material
Constituent 1
Method
- Target gene:
- histidine locus
Species / strainopen allclose all
- Species / strain / cell type:
- other: S. typhimurium TA 98, TA 100
- Species / strain / cell type:
- E. coli WP2 uvr A
- Metabolic activation:
- with and without
- Metabolic activation system:
- Rat liver S9 tissue fraction
- Test concentrations with justification for top dose:
- 1250, 625, 313, 156, 78.1, 39.1, 19.5, and 9.77 µg/plate
Since 25.0 µL of test item solution is used in the preparation of each plate, this permitted a maximum dose level of 1250 µg/plate to be tested in the mutation experiment. - Vehicle / solvent:
- - Vehicle(s)/solvent(s) used: sterile water for injection
- Justification for choice of solvent/vehicle: sterile water for injection is compatible with the survival of the bacteria and the S9 metabolic activity. The test item was found to be soluble at 50.0 mg/ mL. This result permitted a maximum concentration of 1250 µg/plate to be tested in the mutation experiment.
Controlsopen allclose all
- Untreated negative controls:
- yes
- Remarks:
- solvent
- Negative solvent / vehicle controls:
- yes
- Remarks:
- sterile water for injection
- Positive controls:
- yes
- Positive control substance:
- 2-nitrofluorene
- sodium azide
- methylmethanesulfonate
- Remarks:
- Absence of S9
- Untreated negative controls:
- yes
- Remarks:
- solvent
- Negative solvent / vehicle controls:
- yes
- Remarks:
- sterile water for injection
- Positive controls:
- yes
- Positive control substance:
- other: 2-aminoanthracene
- Remarks:
- Presence of S9
- Details on test system and experimental conditions:
- METHOD OF APPLICATION
A single experiment, using the pre-incubation method, was performed.
DURATION
The prepared plates were inverted and incubated for approximately 72 hours at 37°C. After this period of incubation, plates were held at 4°C for 24 hours.
NUMBER OF REPLICATES: Three replicate wells were used at each test point.
Results and discussion
Test resultsopen allclose all
- Species / strain:
- S. typhimurium TA 98
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- no cytotoxicity
- Vehicle controls validity:
- valid
- Untreated negative controls validity:
- valid
- Positive controls validity:
- valid
- Species / strain:
- S. typhimurium TA 100
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- cytotoxicity
- Remarks:
- slight reduction of revertant colonies was observed at the highest dose level in the absence of S9 metabolism
- Vehicle controls validity:
- valid
- Untreated negative controls validity:
- valid
- Positive controls validity:
- valid
- Species / strain:
- E. coli WP2
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- no cytotoxicity
- Vehicle controls validity:
- valid
- Untreated negative controls validity:
- valid
- Positive controls validity:
- valid
Any other information on results incl. tables
Solubility
Solubility of the test item was evaluated in a preliminary trial using sterile water for injection. This solvent was selected since it is compatible with the survival of the bacteria and the S9 metabolic activity. The test item was found to be soluble at 50.0 mg/mL. Since 25.0 µL of test item solution is used in the preparation of each plate, this permitted a maximum dose level of 1250 µg/plate to be tested in the mutation experiment. This concentration corresponds to 5000 µg/plate using the standard method (OECD guideline No. 471).
Main Assay
A single experiment was performed. The test item was assayed at a maximum dose level of 1250 µg/plate and at seven lower dose levels: 625, 313, 156, 78.1, 39.1, 19.5 and 9.77 µg/plate. No precipitation of the test item was noted at the end of the incubation period at any concentration, in the absence or presence of S9 metabolism. Slight reduction of revertant colonies was observed with TA100 all tester strains at the highest dose level in the absence of S9 metabolism indicating a possible toxic effect. No relevant increase in revertant numbers was observed after treatment with test item at any dose level, in any tester strain, in the absence or presence of S9 metabolism. Sterility of the S9 mix and test item solutions was confirmed by the absence of colonies on additional agar plates separately spread with these solutions. Marked increases in revertant numbers were obtained in this test following treatment with the positive control items, indicating that the assay system was functioning correctly.
Analysis of results
Acceptance criteria
The assay was considered valid if the following criteria were met:
1. Mean plate counts for untreated and positive control plates should fall within 2 standard deviations of the current historical mean values.
2. The estimated numbers of viable bacteria/plate should fall in the range of 100 – 500 millions for each strain.
3. No more than 5% of the plates should be lost through contamination or other unforeseen event.
Criteria for outcome of the assays
For the test item to be considered mutagenic, two-fold (or more) increases in mean revertant numbers must be observed at two consecutive dose levels or at the highest practicable dose level only. In addition, there must be evidence of a dose-response relationship showing
increasing numbers of mutant colonies with increasing dose levels.
Evaluation
Results show that mean plate counts for untreated and positive control plates fell within testing facility acceptance criteria based on historical control data (confidence interval: mean value ± 2 standard deviations). The estimated numbers of viable bacteria/plate (titre) fell in the range of 100 - 500 million for each strain. No plates were lost through contamination or cracking. The study was accepted as valid. The test item did not induce two-fold increases in the number of revertant colonies, at any dose level, in any tester strain, in the absence or presence of S9 metabolism.
Applicant's summary and conclusion
- Conclusions:
- Not genotoxic
- Executive summary:
Method
The test item was examined for the ability to induce gene mutations in tester strains of Salmonella typhimurium and Escherichia coli, as measured by reversion of auxotrophic strains to prototrophy, according to OECD guideline 471. The three tester strains TA98, TA100 and WP2 uvrA were used. Experiments were performed both in the absence and presence of metabolic activation, using liver S9 fraction from rats pre-treated with phenobarbitone and betanaphthoflavone. The modified 6 well bacterial mutation method was used. The test item was used as a solution in sterile water for injection.
Observations
In the Main Assay, using the preincubation method, the test item was assayed at a maximum dose level of 1250 µg/plate, corresponding to 5000 µg/plate when the standard method (OECD guideline No. 471) is used, and at seven lower dose levels: 625, 313, 156, 78.1, 39.1, 19.5 and 9.77 µg/plate.
No precipitation of the test item was noted at the end of the incubation period at any concentration, in the absence or presence of S9 metabolism. A slight reduction of revertant colonies was observed with TA100 tester strain at the highest dose level in the absence of S9 metabolism, indicating a possible toxic effect. No relevant increase in revertant numbers was observed after treatment with MTC 2874 at any dose level, in any tester strain, in the absence or presence of S9 metabolism.
Conclusion
It is concluded that the test item does not induce reverse mutation in Salmonella typhimurium or Escherichia coli in the absence or presence of S9 metabolism, under the reported experimental conditions.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.
Although ECHA is providing a lot of online material in your language, part of this page is only in English. More about ECHA’s multilingual practice.
Welcome to the ECHA website. This site is not fully supported in Internet Explorer 7 (and earlier versions). Please upgrade your Internet Explorer to a newer version.
the-echa-website-uses-cookies
find-out-more-on how-we-use-cookies